Jr. Michael Conick Hanley - Chief Business Officer at Spyre Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Business Officer
Issuer ticker
SYRE on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Jr. Michael Conick Hanley since 10 Jun 2025

Reported holdings for Jr. Michael Conick Hanley in Spyre Therapeutics, Inc.

Form 4 holding Chief Business Officer

Aeglea BioTherapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
500,000
Estimated value
Report date
23 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Jr. Michael Conick Hanley in Spyre Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .